Browsing: Hayman

Posts Tagged ‘ Hayman ’

Clash of the Hedge Funds: BioPharm Wars

Dec 1st, 2015 | Filed under: Equity Hedge Funds, Newly Added, Practitioners, Hedge Funds, Personalities in AI

CLVS fell nearly 70% on adverse news from the FDA. The tricky call for investors is whether the drop was (a) just enough, (b) not yet enough, or (c) perhaps too much to discount this blow. Two savvy analysts have recently expressed sharply opposed views on this.Read More